History

National BioService LLC (NBS) was launched in March, 2014 and is the first in Russia commercial research biobank and bioservice. NBS offers its customers a wide range of services focused on the sourcing, processing, analysis and management of biological samples and development of cell and tissue based products.

NBS is a resident of Skolkovo Foundation’s biomed cluster. The team has advanced qualifications from the top-rated UK and US universities and many years of technical and managerial experience at the leading international and domestic biomedical research and service organizations.

We cooperate with more than 90 medical and research centres in Russia. We are guided by high international standards and principles of ethics, transparency and mutually beneficial cooperation with customers and partners.

National BioService is the first and still the only organization in Russia operating according to the requirements of the International Society for Biological and Environmental Repositories – ISBER.

National BioService is also the only developer and manufacturer of tissue microarrays (TMA) in Russia, used to test and develop therapeutic and diagnostic antibodies. This activity is realized with the support of the Skolkovo Foundation.

NBS operates its own laboratory equipped with all the necessary kit for cell and molecular biology and offering high level of security for sample and information storage.

Key Activities

Ethical sourcing and management of bio-specimens with required characteristics, annotation and storage / fixation formats; sample fixation and preservation.

Processing, fragmentation, analysis and quality control of biological samples.

Creation, maintenance, expansion and characterization of cell and tissue cultures.

A variety of molecular biology techniques as well as the bioinformatics analysis supporting their use are available.

Expert consulting and workshops on creation and management of biobanks, biomedical databases, molecular and cellular biology.

Development and manufacturing of normal and/or diseased tissue macroarrays (TMA’s).

Bio-specimen annotation is carried out in FreezerPro software, which is widely used in the world practice of biobanking. FreezerPro allows to store information from physical location to a detailed clinical annotation of a sample, perform an instant search on any parameter, save records of all changes in the system and conduct an audit.

Key therapeutic areas

1. Cardiovascular diseases (IHD, AMI)
2. Oncological diseases (BrCa, CervicalCa, DLBCL, GastricCa, H&N, melanoma, LungCa, PrCa, PancrCa, etc.)
3. Haematological diseases (AML, ALL, CML/CMPD, CLL, MDS, MM)
4. Rheumatological / autoimmune diseases (SLE, MCTD (Sharp’s syndrome), Sjorgen syndrome, IBD/CD, etc.)
5. Endocrine and metabolic diseases (DM, etc.)
6. Defined population groups (elderlies, etc.)
7. Healthy controls

Our Principles

Professionalism


The team behind NBS has advanced academic qualifications from the top-rated UK and US universities and many years of technical and managerial experience at the leading international and domestic biomedical research and service organizations.


Responsibility for the result


The quality of services provided by the NBS is carefully monitored through its own Quality Management System (QMS).


Adherence to standards


NBS strictly complies with the highest ethical standards and current laws and regulations and meet all recognized international standards in biobanking.


Effective partnerships


We develop and support mutually beneficial cooperation with leading health, scientific and research institutions, as well as government agencies, we are building a nationwide network of partners in the field of creating and studying collections of bio-samples.